Cambridge, Mass., October 02, 2026--Obsidian Therapeutics, Inc. Obsidian Nasdaq OBX , a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lym
OBX (OBX) โ Live Session & Technical Brief
Updated Nov 22, 2026 5:47 AM ET ยท Prev Close $12.15
Session Regime & Catalyst Assessment
64% Signal ConvictionControlled Session Consolidation (-1.23%) in Equities
Obx (Obx) is trading within a tight intraday band at $12.00 (-1.23%, 0.60x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, OBX is outperforming the S&P 500 by +2.41%. 14-day RSI stands at 42.9, keeping momentum in a bearish regime.
Cambridge, Mass., October 02, 2026--Obsidian Therapeutics, Inc. Obsidian Nasdaq OBX , a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lym
Price ($12.00) trades relative to 20-day SMA ($13.01) and 50-day SMA ($13.71).
Market & Sector Relative Strength
OBX outperforming the S&P 500 by +2.41%Recent OBX Catalyst Headlines
Verified WireObsidian Therapeutics OBX is back in focus after enrolling the first patient in a registration enabling cohort for its Agni-01 trial of amsoki-cel in advanced melanoma, along with fresh index and capital structure moves.
Cambridge, Mass., August 05, 2026--Obsidian Therapeutics, Inc. Obsidian Nasdaq OBX , a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating lymp
Cambridge, Mass., November 12, 2026--Obsidian Therapeutics, Inc. Obsidian Nasdaq OBX , a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered tumor-infiltrating ly
1โ3 Day Expected Range & Key Level
48% Follow-ThroughMonitor volume expansion above 1.5x RVOL around $13.01 (20-day SMA resistance) for directional breakout confirmation.
Technical Regime (OBX)
BEARISH MA TRENDAbout OBX
Get Instant OBX Catalyst Alerts
Receive an email alert when OBX triggers an unusual volume breakout, options sweep, or rating shift.
OBX Session & Catalyst FAQ
Why is OBX stock trading near flat today?
Obx (Obx) is trading within a tight intraday band at $12.00 (-1.23%, 0.60x relative volume), signaling orderly institutional price discovery without an outlier shock. Relative to benchmarks, OBX is outperforming the S&P 500 by +2.41%. 14-day RSI stands at 42.9, keeping momentum in a bearish regime.
Is OBX stock a buy or sell right now?
Today's session carries a 64% catalyst conviction score on 0.60x relative volume (low participation). Our multi-factor model currently rates OBX as HOLD. Review full valuation, quality, and timing signals on the OBX Buy or Sell Decision Brief โ
What is OBX's intrinsic value and expected trading range?
At $12.00, OBX's modeled 1-to-3 session range is $11.58 โ $12.42, with a key inflection level at $13.01 (20-day SMA resistance). Compare current price against multi-year cash flow projections in the OBX Intrinsic Value & DCF Model โ and Market Cycle Phase Tracker โ
What do RSI and moving averages signal for OBX?
RSI at 42.9 reflects soft below-midline momentum. OBX trades at $12.00 relative to its 20-day SMA ($13.01) and 50-day SMA ($13.71), reflecting a bearish moving-average structure.
Tradestie Flagship Research & Market Hubs
Live institutional catalyst tape ranking liquid gainers, losers, options sweeps, and RVOL surges.
Track spot H100/B200 compute rental rates and frontier LLM inference token economics.
Wafer yield, CoWoS packaging, and HBM bill-of-materials teardown models across AI accelerators.
Monitor engineering velocity and upstream foundry wafer demand inflections across tech leaders.
Live conviction tracking, invalidation guardrails, and thesis health checks on flagship ideas.
Backtest-validated unusual options positioning and open-interest accumulation setups.
Daily ranked quantitative leaderboard with audited forward-return track record vs S&P 500.
High-yield, quality-screened cash-secured put and put-spread income candidates.